{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T06:18:05Z","timestamp":1719901085185},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.ygyno.2008.06.015","type":"journal-article","created":{"date-parts":[[2008,7,18]],"date-time":"2008-07-18T09:00:57Z","timestamp":1216371657000},"page":"S15-S16","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S2","title":["Clinical role of cervical cancer vaccination: When and whom to vaccinate?"],"prefix":"10.1016","volume":"110","author":[{"given":"Aureli","family":"Torn\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Immaculada","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis M.","family":"Puig-Tintor\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaume","family":"Pahisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2008.06.015_bib1","series-title":"GLOBOCAN 2002: cancer incidence. Mortality and prevalence worldwide. IARC CancerBase No 5, Version 2.0.","author":"Ferlay","year":"2004"},{"key":"10.1016\/j.ygyno.2008.06.015_bib2","unstructured":"Merck Research Laboratories. Gardasil\u00d2 (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine). Vaccines and related biological products advisory committee (VRBPAC) briefing document. Presented to VRBPAC on May 18, 2006. Rockville, MD: US Food and Drug Administration, 2006. http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/06\/briefing\/2006-4222B1.pdf (accessed December 21, 2006)."},{"key":"10.1016\/j.ygyno.2008.06.015_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1086\/426867","article-title":"A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women","volume":"191","author":"Brown","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ygyno.2008.06.015_bib4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/aje\/kwf180","article-title":"Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students","volume":"157","author":"Winer","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ygyno.2008.06.015_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijgo.2004.07.013","article-title":"Persistent HPV infection in postmenopausal age women.","volume":"87","author":"Smith","year":"2004","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2008.06.015_bib6","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(06)69479-8","article-title":"Sexual behaviour in context: a global perspective","volume":"368","author":"Wellings","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2008.06.015_bib7","doi-asserted-by":"crossref","unstructured":"De Sanjose S., Cort\u00e9s J., Mendez C., Puig-Tintor\u00e9 L.M., Torne A., Roura E., Castellsague X. Age at sexual initiation and number of sexual partners in the female Spanish population. Results from the AFRODITA survey. Eur J Obstet and Gynecol and Reprod Biol 2008; in press.","DOI":"10.1016\/j.ejogrb.2008.04.005"},{"key":"10.1016\/j.ygyno.2008.06.015_bib8","doi-asserted-by":"crossref","first-page":"A12","DOI":"10.1016\/j.vaccine.2007.11.068","article-title":"Is viral status needed before vaccination?","volume":"26S","author":"Wright","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2008.06.015_bib9","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0020-7292(07)60014-9","article-title":"HPV vaccines","volume":"94","author":"Frazer","year":"2006","journal-title":"Int J Gynecol Obst"},{"key":"10.1016\/j.ygyno.2008.06.015_bib10","first-page":"152","article-title":"HPV vaccines in immunocompromised women and men.","volume":"24S3","author":"Palefsky","year":"2006","journal-title":"Vaccine"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808004393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808004393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T05:56:50Z","timestamp":1545890210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825808004393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0090825808004393"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.06.015","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}